Clinical Trial Update: Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial of eplerenone in Japanese patients with chronic heart failure has completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• eplerenone (eplerenone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2016-10-27